Keywords
Plant-based diet, dietary methods, diet-disease associations, cardiovascular disease risk
This article is included in the Agriculture, Food and Nutrition gateway.
Plant-based diet, dietary methods, diet-disease associations, cardiovascular disease risk
The manuscript has been revised based on the peer review reports. We amended the abstract by adding the study objectives, and clarified or expanded on matters regarding the systematic review's eligibility criteria, selection process, risk of bias assessment, data extraction and analysis. Furthermore, we have corrected our definition for I2 and its usage, and updated the reporting guidelines to be in accordance with the 2020 PRISMA statement.
See the authors' detailed response to the review by Amanda Sainsbury
See the authors' detailed response to the review by Vanessa Bullón-Vela
CVD: Cardiovascular disease
DASH: Dietary Approaches to Stop Hypertension
HR: Hazard ratio
ISI: Institute for Scientific Information
NHLBI: National Heart, Lung, and Blood Institute
OR: Odds ratio
PBD(s): Plant-based diet(s)
PEO: Population, Exposure, and Outcome
PRISMA: Preferred Reporting Items for Systematic reviews and Meta-Analysis
PRISMA-P: Preferred Reporting Items for Systematic reviews and Meta-Analysis protocols
RCTs: Randomized controlled trials
RR: Relative risk
WHO: World Health Organization
95% CIs: 95% Confidence intervals
In the literature, there are widespread inconsistencies with regards to how plant-based diets (PBDs) have been described. This is due to the scarcity of data on how to define a PBD. PBDs are known for emphasising the consumption of foods derived from plants, such as fruits, vegetables, whole grains, legumes, nuts, and seeds. Ostfeld defined a PBD as a diet solely made up of naturally derived plant foods, which does not include any animal foods (e.g. resembling a vegan diet), not exempting eggs or dairy products.1 Other well-known healthy dietary patterns that predominantly contain plant foods are the Mediterranean and Dietary Approaches to Stop Hypertension (DASH) diets. The Mediterranean diet encourages the consumption of healthy plant foods namely vegetables, fruits, whole grains, and nuts, with olive oil as primary source of added fat. Moreover, the Mediterranean diet limits the intake of red and processed meat, poultry, and dairy products and is low in sugar.2 The DASH diet also promotes the consumption of plant foods that are primarily characteristic of a PBD, such as fruits, vegetables, whole grains, nuts, and seeds. Additionally, animal foods are also included in the DASH diet in minimal amounts of red meat, fish, poultry and low-fat dairy products.2
A dietary pattern is the amount, variety, combination of foods and beverages in a diet and the frequency with which they are usually consumed.3,4 Dietary pattern analysis can be predefined (a priori) or data driven (a posteriori); these are two different approaches used to assess dietary patterns. An a posteriori analysis identifies similarities and assesses the variance (i.e. variables or the foods consumed) within a group (i.e. the observations in a data set or rather the study population). Principal component analysis, cluster analysis and factor analysis are among the multivariable statistical techniques utilised to obtain a posteriori scores. In comparison, a priori analysis assigns a score to each nutrient or food, based on existing nutrition knowledge that has a strong health-related focus, and the recommendations relative to a specific population’s dietary guidelines.5–7 Different scoring systems can be used to construct a priori indices, which can subsequently measure adherence to a dietary pattern.8
Dietary indices are based on an individual’s reported intake of either nutrients, foods or the combination of them. Certain foods and nutrients are beneficial for health and consumption thereof should be encouraged to achieve nutritional adequacy, while others are detrimental for health and should be limited and consumed in moderation.9 Dietary indices may include only certain nutrients, foods or food groups in their construction and therefore often do not reflect total dietary intake. Nutrient intake data should preferably be based on country-specific food composition tables, if available. Often energy-adjusted intakes of nutrients or foods are used when constructing dietary indices. Each of the dietary components (e.g. nutrients or foods) included in the dietary index are scored either as absolute using predefined cut-off values or relative based on the distribution of intake (e.g. quintiles).
Predefined cut-off values10 are based on dietary recommendations and are indicative of healthy intakes. Relative scoring depends on the distribution of intake within a specific population; whereby higher intakes are scored higher for the adequacy components and lower for the moderation components. However, relative scoring may not necessarily reflect optimum intakes. The scores of the individual components are summed to obtain the final dietary index score, which can be used as either a continuous variable11 or to group individuals in absolute or relative categories. The total score of a dietary index may range depending on the number of food items, grouping of dietary components, and type of scoring system that is used.6,7 An example of relative scoring is illustrated in the approach by Satjia et al. In their study they created different versions of a PBD index. Food groups were classified as healthy plant foods, less healthy plant foods, and animal foods. These food groups were ranked by quintiles of consumption and graded with positive or reverse scores, depending on which PBD index was calculated.12
Different dietary indices might rank an individual’s PBD adherence differently and create inconsistences, which may consequently influence the diet–disease associations across published studies.13 Evidence-based literature has shown that there are diverse associations reported between PBDs and cardiovascular disease (CVD) and CVD risk. A PBD1 has been encouraged as a lifestyle intervention in two case reports on CVD.14,15 These patients with angina refused surgery, but opted to join a Cardiac Wellness Program that recommended adopting a PBD for the reversal of CVD and/or the prevention of CVD risk.1,14,15 Another study by Lara and colleagues16 reported on the association between a plant-based dietary pattern amongst other dietary patterns and the incidence of CVD hospitalisation due to heart failure. A high adherence to the plant-based dietary pattern was statistically significantly associated with a decreased likelihood of incident heart failure. However, several studies have focussed on the association of PBDs with CVD risk, specifically the reduced risk of developing hypertension and type 2 diabetes.13,17–19
Nutrition-based epidemiological studies are crucial to generate findings on the association between a PBD and health outcomes. Evidence of these associations may be inconsistent amongst studies that are conducted across different regions and countries. The latter may be due to studies utilising different dietary pattern analysis and scoring systems to construct plant-based diet indices for measuring adherence to a PBD. Furthermore, the extent of such discrepancies between the definitions of a PBD and measures of adherence as they apply globally; to the study of the associations between adherence to a PBD and CVD risk, warrants further investigation. Thus, considering these variations, it could prove valuable to investigate to what extent different methods may influence study findings. This is important prior to conducting studies in under-researched populations such as Africa, where there is a scarcity of resources and paucity of data on the association of PBDs with CVD risk. Therefore, this review aims to address this gap in the literature on PBD studies.
This protocol is for a systematic review of studies on the association of PBD with CVD risk in order to:
Across studies of the association of PBD with CVD risk, the review will seek to address the following questions:
Inclusion criteria
Observational (i.e. cohort, cross-sectional and case–control) studies reporting on the association between PBDs and CVD risk will be included in the review. The population, exposure, and outcome (PEO) strategy will be applied to identify relevant studies. Study populations will consist of men and/or women (aged 18 years and above), irrespective of their ethnicity. Studies published will be included without language restriction. We will include studies that assessed adherence to a PBD, using any definition including, vegan and/or vegetarian diets to investigate its association with CVD risk. However, only studies with a clear description of a PBD as a dietary exposure will be included. These studies should also report which dietary methods they used to measure adherence to a PBD. We will focus on assessing the association between adherence to a PBD and CVD risk as a health outcome. Studies will be eligible if: measurements for hypertension and/or overweight/obesity, and/or biomarkers measurements for assessing dysglycaemia and/or diabetes mellitus and/or dyslipidaemia were reported. Studies will also be included if they assessed CVD risk factors in combination as metabolic syndrome and/or reported an absolute CVD risk score. In addition to this, studies reporting on major cardiovascular outcomes, such as myocardial infarction and/or coronary heart disease, stroke and/or cerebrovascular disease and/or sudden cardiac death will be included in the review.
Exclusion criteria
The exclusion criteria will pertain to studies that were conducted in children, female participants that are pregnant or breastfeeding or animals. Studies that have reported on the Mediterranean and/or DASH diet/dietary patterns which are predominantly plant-based will be excluded from the primary analysis. However, such studies will be included in our secondary analysis; if the authors did not state that they were assessing a PBD as their exposure variable. Published studies without primary data such as reviews, letters to the editor, commentaries and/or editorials will not be eligible. After full-text assessment, studies that have investigated the associations of PBD with CVD risk, but have not reported the risk estimates, measures of correlation and regression analyses will be excluded. Studies will also be excluded if they do not have the necessary supplementary materials or have insufficient information for estimating adherence to a PBD, and such information cannot be obtained from the authors of the study.
The literature search will be performed in PubMed–Medline and Scopus databases amongst other biomedical databases within the EBSCOhost platform, i.e. Global Health. The databases will be searched for population and/or hospital-based observational studies that were published up to August 2021. Manual searches will be conducted by screening the reference lists of the eligible studies to identify other articles of interest. The ISI Web of Science will be utilised to trace the citations.
Grey literature
The World Health Organization (WHO) website will be browsed according to themes, i.e. nutrition and non-communicable diseases for any pertinent information or reports available from the Global Health Observatory data repository. The Institute for Scientific Information (ISI) Web of Science will be searched for conference proceedings that are relevant to the review questions. Conference abstracts will be retrieved from the conference websites. If necessary, authors or experts in the field will be contacted for any unpublished studies with relevant data.
A comprehensive literature search will be conducted to identify eligible studies without any restriction to country. A search strategy will be applied in all electronic databases and adapted accordingly. The search terms will utilise the following key words as free texts and/or medical subject headings to find relevant studies: plant-based diet OR plant-based OR adherence to a plant-based diet OR healthy dietary pattern AND dietary pattern analysis OR a priori OR a posteriori OR dietary indices AND cardiovascular disease OR heart disease OR ischaemic/ischemic chest pain OR myocardial infarction OR heart attack OR coronary artery disease OR congestive heart failure OR cardiac arrest OR stroke OR cerebrovascular disease OR sudden death OR sudden cardiac death OR hypertension OR high blood pressure OR diabetes OR dysglycaemia OR dysglycemia OR dyslipidaemia OR dyslipidemia OR hyperglycaemia OR hyperglycemia OR prediabetes OR impaired glucose tolerance OR impaired fasting glycaemia/glycemia OR obesity OR overweight OR metabolic syndrome OR cardiovascular risk score OR cardiovascular risk model.
EndNote X8 citation management software (RRID:SCR_014001) will be used to identify any duplicates; Zotero (RRID:SCR_013784) is an open-access alternative. Duplicate records will be removed prior to screening. If multiple publications from the same study are found the most comprehensive publication will be included. The identified records will be exported to the Rayyan application for systematic reviews (RRID:SCR_017584),20 which will be used to manage and screen the identified records.
The Rayyan application will be utilised during the selection process. Two reviewers will independently screen the identified titles and abstracts. The inclusion and exclusion criteria will serve as guide for the reviewers to select eligible records and studies. After completing the titles and abstracts screening, the two reviewers will discuss any discrepancies and reach a consensus to include or exclude the record. Subsequently, the full text of all eligible records will be retrieved. Full text will be reviewed independently by the two reviewers and checked by a third reviewer for consensus. The Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) flow diagram will be utilised to summarise the study selection process. Exclusion reasons will be provided and documented for all the full text reviewed studies, which do not meet the criteria of the review.
Two reviewers will independently extract data from all eligible studies, using the data collection form for RCTs and non-RCTs from the Cochrane Collaboration21 that will be adapted if necessary. Disagreements will be discussed with a third reviewer and resolved by consensus. Data items will be captured in Microsoft Excel (RRID:SCR_016137) spreadsheets; Google Sheets (RRID:SCR_017679) is an open-access alternative. The following general data items will be extracted from each study: the first author’s name, year of publication, geographical region, country, sample size and study design. The PEO strategy will also be utilised to extract study-specific data. For example, data related to the baseline characteristics of cohort study participants, and the duration of follow-up will be extracted. Study-specific data will include the demographics of study participants such as age, sex and ethnicity, the dietary exposure and how it was defined, how adherence was measured including the dietary assessment method and reference period that was used, how the food intake was quantified such as the level of intake (e.g., tertiles of consumption), which dietary pattern analysis approach was applied to construct the dietary index, also which health outcome was assessed and how the outcomes were ascertained. Moreover, we will extract data on which covariates were adjusted for in the regression models of the included studies, and report on the measurement of potential confounders.
The risk of bias will be assessed independently by two reviewers. Each study will be appraised using the National Heart, Lung, and Blood Institute (NHLBI) Quality Assessment Tool for Observational studies22 to rate the methodological quality. The NHLBI tools will be utilised to assess the risk of bias for all observational study types namely cross-sectional, cohort and case-control studies. The quality scores of the included studies will be calculated based on 14 criteria for cross-sectional and cohort studies and 12 criteria for case-control studies. This risk of bias assessment tool was selected because it was developed by a working group assessing cardiovascular risk which is the outcome of interest for our systematic review. Moreover, the NHLBI tools were developed using a rigorous approach and are accompanied by a user-friendly guide that assists the reviewer(s) to answer/interpret the criteria that are included in each tool. All the included studies will be categorised as having a methodological quality that is good (score > 11), fair (score 6-9), or poor (score < 6).23
Synthesis, analysis, and assessment of heterogeneity
Descriptive data will be presented by the major study characteristics of the eligible studies such as the mean or median age with the estimates of variance, sex proportions and ethnicity of the study participants. A list of all the PBD definitions identified across the eligible studies will be compiled and presented in a table depicting the differences and similarities. We will quantitatively synthesise prevalence data to evaluate the level of adherence to a PBD across studies. The prevalence of adherence to a PBD will be summarised by geographical region and countries, and which method was used to construct the dietary index. Association data of adherence to a PBD with CVD risk and/or CVD will be analysed according to study design, showing the reported measures of association by major CVD risk such as the odds ratio (OR), CVD risk score and/or CVD such as hazard ratio (HR) or risk ratio (RR).
Meta-analytic techniques will be applied to combine the data from studies investigating the association between adherence to a PBD and CVD risk: with sufficient data depending on the study design, assessing the same dietary exposure and health outcome, and with comparable measures of association. Separate forest plots will be generated to present the summary statistics for cross-sectional and/or case–control studies (e.g. ORs) and cohort studies (e.g. RRs) with their 95% confidence intervals (95% CIs). A random-effects model will be used to calculate the pooled estimated measure of association of study populations with adherence to a PBD and at risk of developing or having CVD. The leave-one-out sensitivity analyses will also be conducted to assess the likely influence of studies on the pooled estimates in meta-analyses. Subgroup analyses will be performed by geographical regions and country, sample size, sex, participant status, the type of dietary pattern analysis approach and scoring system, and study quality. Meta-analyses will be stratified according to study population, the type of PBD definition, if the same criteria were used to assess dietary exposure, and by CVD risk for studies that have assessed the same health outcome. Thus, grouping all the studies that investigated association in study participants with similar demographics, using an identical dietary exposure and assessing the same CVD risk and/or CVD.
Heterogeneity across studies included in the meta-analysis will be assessed using the Cochrane Q statistic. The degree of heterogeneity will be determined using I2, which indicates the proportion of variation in the observed effects as a result of sampling error and variation in the true effects.24 Publication bias will be evaluated graphically with the funnel plot asymmetry test and statistically using Egger’s test.25,26 Sensitivity analysis will be applied to evaluate and confirm the robustness of the findings. The Tweedie and Duval trim and fill methods will be used to impute missing studies and examine the plausibility of the imputed studies.27 The data analysis will be conducted using the ‘meta’ package of the statistical software R (RRID:SCR_019055; The R Foundation for statistical computing, Vienna, Austria). A narrative summary will be provided for studies with significant differences to allow pooling of the estimates via meta-analysis.
This study has a systematic review and meta-analysis design, which will assess published data and does not require ethical approval. This review will form part of a PhD thesis by publication that will be submitted at Stellenbosch University for degree purposes. The PhD study proposal has obtained ethics approval from Stellenbosch University Health Research Ethics Committee (SU HREC number: S19/03/056). The results will be published in peer-reviewed journals. Study findings will be presented at relevant research meetings and conferences.
This systematic review and meta-analysis will investigate the association of PBD adherence with CVD risk profile from a global perspective. Published studies have applied various dietary methods to assess adherence to a PBD, therefore, this study aims to evaluate which PBD definitions are utilised and assess the accuracy of PBD indices across high and low-to-middle income countries. A considerable degree of heterogeneity may be present due to the different dietary methods and including studies with small sample sizes may be a limitation when performing the meta-analysis. Statistical techniques will be applied to collate and report robust findings in this systematic review.
Amendments to the study protocol, if any, will be published in accordance with the 2020 PRISMA-P guidelines.28
This systematic review will aim to highlight the inconsistencies in defining a PBD and the need for a universal definition. It will summarise which methods are commonly used to construct dietary indices that measure adherence to a PBD. Furthermore, it will investigate the association of adherence to a PBD with CVD risk from a global perspective. This may be important to improve the global acceptance of these study findings to inform policymakers and practitioners.
Figshare: PRISMA-P checklist for “Protocol for a systematic review and meta-analysis: to investigate the association of adherence to plant-based diets with cardiovascular disease risk” https://doi.org/10.6084/m9.figshare.14988249.v1.29
Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).
TL and APK conceived and designed the protocol. TL drafted the manuscript. APK, AEZ, MF, SD and RTE critically revised the manuscript for methodological and clinical content. All authors approved the final version of the manuscript.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Competing Interests: Amanda Salis owns 50% of the shares in Zuman International Pty Ltd, which receives royalties and other payments for educational resources and services in adult weight management and research methodology.
Reviewer Expertise: Obesity and methodology used to assess treatments (e.g., fundamental studies in animals; clinical trials; epidemiological studies; systematic reviews and meta-analyses).
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Yes
Are the datasets clearly presented in a useable and accessible format?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Nutrition Epidemiology
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Yes
Are the datasets clearly presented in a useable and accessible format?
Yes
References
1. Borenstein M, Higgins JP, Hedges LV, Rothstein HR: Basics of meta-analysis: I2 is not an absolute measure of heterogeneity.Res Synth Methods. 2017; 8 (1): 5-18 PubMed Abstract | Publisher Full TextCompeting Interests: No competing interests were disclosed.
Reviewer Expertise: Obesity and methodology used to assess treatments (e.g., fundamental studies in animals; clinical trials; epidemiological studies; systematic reviews and meta-analyses).
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||
---|---|---|
1 | 2 | |
Version 2 (revision) 28 Jun 22 |
read | |
Version 1 06 Aug 21 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)